These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1136 related items for PubMed ID: 2832289

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Corticotropin releasing hormone: relevance to normal physiology and to the pathophysiology and differential diagnosis of hypercortisolism and adrenal insufficiency.
    Gold PW, Kling MA, Khan I, Calabrese JR, Kalogeras K, Post RM, Avgerinos PC, Loriaux DL, Chrousos GP.
    Adv Biochem Psychopharmacol; 1987; 43():183-200. PubMed ID: 3035886
    [Abstract] [Full Text] [Related]

  • 3. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J, Perry L, Medbak S, Monson J, Savage M, Besser M, Grossman A.
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [Abstract] [Full Text] [Related]

  • 4. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL.
    N Engl J Med; 1984 Mar 08; 310(10):622-6. PubMed ID: 6319991
    [Abstract] [Full Text] [Related]

  • 5. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J, Usui T, Tsukada T, Nakai Y, Koh T, Ishihara T, Tanaka I, Uchida K, Yoshimasa T, Nakano R.
    J Clin Endocrinol Metab; 1990 Dec 08; 71(6):1624-31. PubMed ID: 2172283
    [Abstract] [Full Text] [Related]

  • 6. CRH test after pituitary microsurgery suggests tertiary adrenocortical insufficiency in successful operated patients with Cushing's disease.
    Schrell U, Fahlbusch R, Buchfelder M, Riedl S, Stalla GK, Müller OA.
    Horm Metab Res Suppl; 1987 Dec 08; 16():64-5. PubMed ID: 2832294
    [Abstract] [Full Text] [Related]

  • 7. Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease.
    Dickstein G, DeBold CR, Gaitan D, DeCherney GS, Jackson RV, Sheldon WR, Nicholson WE, Orth DN.
    J Clin Endocrinol Metab; 1996 Aug 08; 81(8):2934-41. PubMed ID: 8768855
    [Abstract] [Full Text] [Related]

  • 8. Corticotropin-releasing factor in humans. II. CRF stimulation in patients with diseases of the hypothalamo-pituitary-adrenal axis.
    Müller OA, Stalla GK, von Werder K.
    Horm Res; 1987 Aug 08; 25(4):185-98. PubMed ID: 3034758
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Corticotropin-releasing factor (CRF): stimulation in normal controls and in patients with Cushing's syndrome.
    Müller OA, Hartwimmer J, Hauer A, Kaliebe T, Schopohl J, Stalla GK, von Werder K.
    Psychoneuroendocrinology; 1986 Aug 08; 11(1):49-60. PubMed ID: 3010360
    [Abstract] [Full Text] [Related]

  • 11. Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    Suda T, Tozawa F, Dobashi I, Horiba N, Ohmori N, Yamakado M, Yamada M, Demura H.
    J Clin Invest; 1993 Dec 08; 92(6):2790-5. PubMed ID: 8254033
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Importance of the CRH (corticotropin releasing hormone) test in the differential diagnosis of Cushing's syndrome].
    Korsić M, Plavsić V, Besenski N, Skorić T, Giljević Z, Zarković K, Zarković N, Zaninović L, Paladino J, Aganović I.
    Lijec Vjesn; 2001 Dec 08; 123(7-8):165-8. PubMed ID: 11729609
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E, Arvat E, Ramunni J, Colao A, Gianotti L, Deghenghi R, Lombardi G, Camanni F.
    J Clin Endocrinol Metab; 1997 Aug 08; 82(8):2439-44. PubMed ID: 9253314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Diagnosis and differential diagnosis of Cushing's syndrome].
    Penezić Z, Zarković M, Vujović S, Drezgić M.
    Srp Arh Celok Lek; 2006 Aug 08; 134(11-12):558-66. PubMed ID: 17304774
    [Abstract] [Full Text] [Related]

  • 18. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB.
    J Clin Endocrinol Metab; 2003 Nov 08; 88(11):5299-306. PubMed ID: 14602765
    [Abstract] [Full Text] [Related]

  • 19. Pathophysiology of Cushing's disease.
    Fehm HL, Voigt KH.
    Pathobiol Annu; 1979 Nov 08; 9():225-55. PubMed ID: 225710
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C, Pecori Giraldi F, de Martin M, Cavagnini F.
    J Clin Endocrinol Metab; 1999 Feb 08; 84(2):440-8. PubMed ID: 10022398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 57.